May 23, 2016.
Three of Sanofi's (Paris, France) top executives are leaving the company as its "2020 strategic roadmap" gets under way.
Pascale Witz, executive vice president of diabetes and cardiovascular, Carsten Hellmann, executive vice president of Merial, Sanofi’s animal health division, and Suresh Kumar, executive vice president of external affairs, have announced their intention to leave the company.
Hellmann has accepted a position as president and CEO of ALK (Horsholm, Denmark).
Can Data and AI Deliver Whole-Person Health?
July 9th 2024Executives in the life sciences and medical device industries see promise in artificial intelligence (AI) and medical technologies, but must also navigate the changing healthcare ecosystem, varied stakeholder needs, and the impact of AI on market access and commercialization strategies.